Company Filing History:
Years Active: 2017-2022
Title: Innovations of Anders Tsirk in Pharmaceutical Manufacturing
Introduction
Anders Tsirk is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the production of lyophilized drug substances. With a total of five patents to his name, Tsirk's work has had a considerable impact on the industry.
Latest Patents
One of Anders Tsirk's latest patents focuses on the manufacture of degarelix. This invention provides methods for producing a lyophilized degarelix product which, upon reconstitution with water for injection in an amount of 20 mg/ml, shows a viscosity of up to 15 mPas. Additionally, the invention includes a lyophilized degarelix drug substance that demonstrates, upon dissolution in water in an amount of 20 mg/ml, a viscosity of up to 3.2 mPas. The processes outlined in this patent are crucial for ensuring the quality and efficacy of the drug.
Career Highlights
Anders Tsirk has been associated with Ferring B.V., a company known for its innovative pharmaceutical solutions. His work at Ferring has allowed him to develop and refine methods that enhance the production of critical medications. Tsirk's expertise in pharmaceutical manufacturing has positioned him as a key figure in his field.
Collaborations
Throughout his career, Anders Tsirk has collaborated with several professionals, including Grégoire Schwach and Anders Nilsson. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical technologies.
Conclusion
Anders Tsirk's contributions to the field of pharmaceutical manufacturing, particularly through his patents on degarelix, highlight his role as an influential inventor. His work continues to shape the industry and improve drug production processes.